Targeting Membrane Trafficking As a Strategy for Cancer Treatment
Overview
Affiliations
Membrane trafficking is emerging as an attractive therapeutic strategy for cancer. Recent reports have found a connection between Wnt signaling, receptor-mediated endocytosis, V-ATPase, lysosomal activity, and macropinocytosis through the canonical Wnt pathway. In macropinocytic cells, a massive internalization of the plasma membrane can lead to the loss of cell-surface cadherins, integrins, and other antigens that mediate cell-cell adhesion, favoring an invasive phenotype. V-ATPase is a key regulator in maintaining proper membrane trafficking, homeostasis, and the earliest developmental decisions in the vertebrate development model system. Here, we review how the interference of membrane trafficking with membrane trafficking inhibitors might be clinically relevant in humans.
Andersen G, Ianevski A, Resell M, Pojskic N, Rabben H, Geithus S NPJ Syst Biol Appl. 2024; 10(1):127.
PMID: 39496635 PMC: 11535201. DOI: 10.1038/s41540-024-00455-0.
Na,K-ATPase activity promotes macropinocytosis in colon cancer via Wnt signaling.
Tejeda-Munoz N, Azbazdar Y, Sosa E, Monka J, Wei P, Binder G Biol Open. 2024; 13(5).
PMID: 38713004 PMC: 11139033. DOI: 10.1242/bio.060269.
Membrane trafficking in breast cancer progression: protein kinase D comes into play.
Gutierrez-Galindo E, Yilmaz Z, Hausser A Front Cell Dev Biol. 2023; 11:1173387.
PMID: 37293129 PMC: 10246754. DOI: 10.3389/fcell.2023.1173387.
Petty H Metabolites. 2023; 13(1).
PMID: 36676966 PMC: 9866082. DOI: 10.3390/metabo13010041.
Patel A, Rasheed A, Reilly I, Pareek Z, Hansen M, Haque Z Pharmaceuticals (Basel). 2022; 15(11).
PMID: 36355554 PMC: 9698530. DOI: 10.3390/ph15111380.